Park; Peter
Patent Applications and Registrations
Patent applications and USPTO patent grants for Park; Peter.The latest application filed is for "bicyclic peptide ligands specific for cd137".
- Park; Peter - Lincoln MA
- Park; Peter - Lexington MA
- Park; Peter - Somerville MA
- Park; Peter - New York NY
- Park; Peter - Milpitas CA
- Park, Peter - Wheeling IL
- Park; Peter - Beaconsfield CA
- Park; Peter - Santa Clara CA
Trademarks
| Patent | Date |
|---|---|
| Heterotandem bicyclic peptide complexes Grant 11,453,703 - Keen , et al. September 27, 2 | 2022-09-27 |
| Bicyclic peptide ligands specific for Nectin-4 Grant 11,453,702 - Beswick , et al. September 27, 2 | 2022-09-27 |
| Methods for treating cancer Grant 11,414,488 - Bennett , et al. August 16, 2 | 2022-08-16 |
| Bicyclic Peptide Ligands Specific For Cd137 App 20220213145 - CHEN; Liuhong ; et al. | 2022-07-07 |
| Bicyclic Peptide Ligands Specific For Nectin-4 App 20220089643 - BESWICK; Paul ; et al. | 2022-03-24 |
| Bicyclic peptide ligand specific for CD137 Grant 11,261,214 - Chen , et al. March 1, 2 | 2022-03-01 |
| Bicyclic peptide ligands specific for Nectin-4 Grant 11,180,531 - Beswick , et al. November 23, 2 | 2021-11-23 |
| Heterotandem Bicyclic Peptide Complexes App 20210299210 - Keen; Nicholas ; et al. | 2021-09-30 |
| Bicyclic Peptide Ligands Specific For Nectin-4 App 20210269480 - BESWICK; Paul ; et al. | 2021-09-02 |
| Methods For Treating Cancer App 20200354456 - BENNETT; Gavin ; et al. | 2020-11-12 |
| Bicyclic Peptide Ligand Specific For Cd137 App 20200255477 - Kind Code | 2020-08-13 |
| Bicyclic Peptide Ligands Specific For Nectin-4 App 20190389906 - Beswick; Paul ; et al. | 2019-12-26 |
| Heterotandem Bicyclic Peptide Complexes App 20190307836 - Keen; Nicholas ; et al. | 2019-10-10 |
| CD37-Binding Molecules and Immunoconjugates Thereof App 20190218303 - Deckert; Jutta ; et al. | 2019-07-18 |
| Cyclic HIV-1 Env V3 glycopeptide immunogens Grant 10,286,057 - Haynes , et al. | 2019-05-14 |
| CD37-binding molecules and immunoconjugates thereof Grant 10,202,460 - Deckert , et al. Feb | 2019-02-12 |
| Electroluminescence Testable Photovoltaic Modules Having Shade Management Solutions App 20170133983 - Moslehi; Mehrdad M. ; et al. | 2017-05-11 |
| CD37-Binding Molecules and Immunoconjugates Thereof App 20160326258 - DECKERT; Jutta ; et al. | 2016-11-10 |
| CD37-binding molecules and immunoconjugates thereof Grant 9,346,887 - Deckert , et al. May 24, 2 | 2016-05-24 |
| V3 Immunogens App 20160106827 - Haynes; Barton F. ; et al. | 2016-04-21 |
| CD37-binding molecules and immunoconjugates thereof Grant 8,765,917 - Deckert , et al. July 1, 2 | 2014-07-01 |
| CD37-Binding Molecules and Immunoconjugates Thereof App 20130295104 - DECKERT; Jutta ; et al. | 2013-11-07 |
| CD37-Binding Molecules and Immunoconjugates Thereof App 20110256153 - Deckert; Jutta ; et al. | 2011-10-20 |
| Substrate analog for murg, methods of making same and assays using same App 20040180813 - Kahne, Suzanne Walker ; et al. | 2004-09-16 |
| Substrate analogs for MurG, methods of making same and assays using same Grant 6,703,213 - Kahne , et al. March 9, 2 | 2004-03-09 |
| Substrate analogs for MurG, methods of making same and assays using same App 20020182661 - Kahne, Suzanne Walker ; et al. | 2002-12-05 |
| Spaceborne scatterometer Grant 6,137,437 - Lin , et al. October 24, 2 | 2000-10-24 |
| Shapable catheter using exchangeable core and method of use Grant 5,993,462 - Pomeranz , et al. November 30, 1 | 1999-11-30 |
| Method for forming a stent in situ Grant 5,899,917 - Edwards , et al. May 4, 1 | 1999-05-04 |
| Shapable catheter using exchangeable core and method of use Grant 5,882,346 - Pomeranz , et al. March 16, 1 | 1999-03-16 |
| NCAGE Code | 8PP73 | PARK, PETER |
| NCAGE Code | 3ESB7 | PARK PETER!DBA METABRID TECHNOLOGIES |
| CAGE Code | 3ESB7 | PARK, PETER METABRID TECHNOLOGIES |
| DUNS | 117643777 | Park, Peter |
| SEC | 0001576906 | Park Peter |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 